Cognition Therapeutics Ownership | Who Owns Cognition Therapeutics?

Cognition Therapeutics Ownership Summary

Cognition Therapeutics is owned by 24.74% institutional investors, 2.27% insiders, and 72.99% retail investors. Bios capital management, lp is the largest institutional shareholder, holding 9.42% of CGTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.30% of its assets in Cognition Therapeutics shares.

CGTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cognition Therapeutics	24.74%	2.27%	72.99%
Sector	Healthcare Stocks	232.86%	10.65%	-143.51%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bios capital management, lp	6.00M	9.42%	$8.10M
Vanguard group	3.32M	4.26%	$4.48M
Davenport	2.89M	3.98%	$2.20M
Northwestern mutual wealth management	2.06M	2.64%	$260.98M
Tang capital management	1.20M	1.88%	$1.62M
Blackrock funding, inc. /de	1.01M	1.30%	$1.37M
Chescapmanager	997.03K	1.28%	$1.35M
Renaissance	969.51K	1.24%	$1.31M
Geode capital management	873.95K	1.12%	$1.18M
Jane street group	614.26K	0.79%	$829.25K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bios capital management, lp	6.00M	9.11%	$8.10M
Cm management	200.00K	0.23%	$270.00K
Northwestern mutual wealth management	2.06M	0.17%	$260.98M
Chescapmanager	997.03K	0.11%	$1.35M
American financial group	205.00K	0.10%	$276.75K
Tang capital management	1.20M	0.06%	$1.62M
Hilton capital management	548.95K	0.06%	$741.08K
Fca corp /tx	52.54K	0.02%	$70.92K
Castle wealth management	44.01K	0.02%	$59.41K
Davenport	2.89M	0.01%	$2.20M

Top Buyers

Holder	Shares	% Assets	Change
Northwestern mutual wealth management	2.06M	0.17%	2.04M
Tang capital management	1.20M	0.06%	1.20M
Vanguard group	3.32M	0.00%	635.91K
Quadrature capital	263.09K	0.00%	263.09K
Renaissance	969.51K	0.00%	256.01K

Top Sellers

Holder	Shares	% Assets	Change
Acadian asset management	-	-	-701.94K
Awm investment company	-	-	-650.00K
Timelo investment management	-	-	-361.40K
Jane street group	614.26K	0.00%	-311.89K
Aigh capital management	-	-	-300.77K

New Positions

Holder	Shares	% Assets	Change	Value
Tang capital management	1.20M	0.06%	1.20M	$1.62M
Quadrature capital	263.09K	0.00%	263.09K	$357.80K
Graham capital management	226.56K	0.00%	226.56K	$305.85K
Texas capital bank wealth management services	123.30K	0.01%	123.30K	$166.45K
Ci private wealth	72.11K	0.00%	72.11K	$97.35K

Sold Out

Holder	Change
Jpmorgan chase	-69.00
Opal wealth advisors	-500.00
Nova wealth management	-500.00
Ifp advisors	-1.00K
Coldstream capital management	-1.24K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	51	-26.09%	19,284,989	-9.33%	24	2.22%	19	-64.81%	9	80.00%
Sep 30, 2025	64	33.33%	21,298,058	89.46%	33	10.73%	49	172.22%	4	-42.86%
Jun 30, 2025	48	-	11,241,507	-3.32%	17	4.99%	18	-10.00%	7	-36.36%
Mar 31, 2025	1	-97.78%	6,000,000	-45.80%	9	1.29%	-	-100.00%	-	-100.00%
Dec 31, 2024	30	-23.08%	10,129,593	138.12%	25	22.62%	13	-18.75%	6	50.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.06M	2.30%	-
Vanguard Institutional Extnd Mkt Idx Tr	874.81K	0.98%	-
Fidelity Extended Market Index	421.39K	0.47%	-1.53K
Extended Equity Market Fund E	156.05K	0.17%	-
Blackrock Extended Mkt Fund CF	156.05K	0.17%	-
Extended Equity Market Fund B	156.05K	0.17%	-
BlackRock Extended Equity Market K	64.70K	0.16%	-27.00
Fidelity Total Market Index	143.77K	0.16%	-
Extended Equity Market Fund K	132.87K	0.15%	-973.00
Fidelity Series Total Market Index	112.40K	0.13%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 16, 2026	Doyle John Brendan	Chief Financial Officer	Buy	$11.30K
Apr 16, 2026	Ricciardi Lisa	CEO & President	Buy	$10.09K
Apr 16, 2026	Caggiano Anthony	Chief Medical Officer	Buy	$11.10K
Jan 31, 2025	Ricciardi Lisa	CEO & President	Buy	$30.00K
Mar 14, 2024	Ricciardi Lisa	CEO & President	Buy	$9.97K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	-
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	1	-

CGTX Ownership FAQ

Who Owns Cognition Therapeutics?

Cognition Therapeutics shareholders are primarily institutional investors at 24.74%, followed by 2.27% insiders and 72.99% retail investors. The average institutional ownership in Cognition Therapeutics's industry, Biotech Stocks , is 382.13%, which Cognition Therapeutics falls below.

Who owns the most shares of Cognition Therapeutics?

Cognition Therapeutics’s largest shareholders are Bios capital management, lp (6M shares, 9.42%), Vanguard group (3.32M shares, 4.26%), and Davenport (2.89M shares, 3.98%). Together, they hold 17.65% of Cognition Therapeutics’s total shares outstanding.

Does Blackrock own Cognition Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Cognition Therapeutics.

Who is Cognition Therapeutics’s biggest shareholder by percentage of total assets invested?

Bios capital management, lp is Cognition Therapeutics’s biggest shareholder by percentage of total assets invested, with 9.11% of its assets in 6M Cognition Therapeutics shares, valued at 8.1M$.

Who is the top mutual fund holder of Cognition Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cognition Therapeutics shares, with 2.30% of its total shares outstanding invested in 2.06M Cognition Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools